Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
CANCER:
Juvenile Myelomonocytic Leukemia
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Leukemia (1822
)
Acute Myelogenous Leukemia (825
)
Acute Lymphocytic Leukemia (378
)
Chronic Lymphocytic Leukemia (279
)
Chronic Myeloid Leukemia (261
)
B Acute Lymphoblastic Leukemia (157
)
T Acute Lymphoblastic Leukemia (38
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (18
)
Chronic Myelomonocytic Leukemia (16
)
Prolymphocytic Leukemia (14
)
Acute Promyelocytic Leukemia (12
)
Chronic Eosinophilic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
Leukemia (1822
)
Acute Myelogenous Leukemia (825
)
Acute Lymphocytic Leukemia (378
)
Chronic Lymphocytic Leukemia (279
)
Chronic Myeloid Leukemia (261
)
B Acute Lymphoblastic Leukemia (157
)
T Acute Lymphoblastic Leukemia (38
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (18
)
Chronic Myelomonocytic Leukemia (16
)
Prolymphocytic Leukemia (14
)
Acute Promyelocytic Leukemia (12
)
Chronic Eosinophilic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
›
Associations
(4)
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
No biomarker
Juvenile Myelomonocytic Leukemia
No biomarker
Juvenile Myelomonocytic Leukemia
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
azacitidine
Sensitive: A1 - Approval
azacitidine
Sensitive
:
A1
KRAS mutation
Juvenile Myelomonocytic Leukemia
KRAS mutation
Juvenile Myelomonocytic Leukemia
decitabine
Sensitive: C4 – Case Studies
decitabine
Sensitive
:
C4
decitabine
Sensitive: C4 – Case Studies
decitabine
Sensitive
:
C4
ETV6-FLT3 fusion
Juvenile Myelomonocytic Leukemia
ETV6-FLT3 fusion
Juvenile Myelomonocytic Leukemia
gilteritinib
Sensitive: C4 – Case Studies
gilteritinib
Sensitive
:
C4
gilteritinib
Sensitive: C4 – Case Studies
gilteritinib
Sensitive
:
C4
SETBP1 mutation + NRAS mutation
Juvenile Myelomonocytic Leukemia
SETBP1 mutation + NRAS mutation
Juvenile Myelomonocytic Leukemia
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
trametinib
Sensitive: D – Preclinical
trametinib
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
